To market a medicinal product in the United Kingdom, the Marketing Authorisation Holder (MAH) must establish and maintain a compliant pharmacovigilance (PV) system in line with UK Good Pharmacovigilance Practice (GVP) requirements and under the oversight of the Medicines and Healthcare products Regulatory Agency (MHRA). A robust PV system must be in place prior to product launch and maintained throughout the entire product lifecycle.

At ComplyX Consulting Ltd, we provide flexible pharmacovigilance support tailored to your organisation’s strategic and commercial objectives. Whether you require a fully outsourced PV system or support for specific operational components, we can deliver scalable, compliant solutions aligned with regulatory expectations.

View our “Standalone Services” section for examples of the specialist services we offer.